John Hulleman, Ph.D.
Assistant Professor of Ophthalmology and Pharmacology
Dr. Hulleman is originally from Wausau, Wisconsin. He received dual undergraduate degrees in biology and chemistry at the University of St. Thomas in St. Paul, Minnesota.
He earned a Ph.D. in medicinal chemistry and molecular pharmacology at Purdue University. There, under the guidance of Dr. Jean-Christophe Rochet, he studied how misfolded proteins cause early-onset Parkinson’s disease.
He did postdoctoral research in the laboratory of Dr. Jeffery Kelly at The Scripps Research Institute, where he focused on how an R345W mutation in fibulin-3 causes a rare, early-onset form of macular degeneration.
In 2014, Dr. Hulleman joined UT Southwestern’s Department of Ophthalmology. His research focuses on novel therapeutic approaches for eye diseases, including age-related macular degeneration, retinal dystrophies (e.g., Stargardt disease) and retinitis pigmentosa.
Dr. Hulleman has a secondary appointment in the Department of Pharmacology and is affiliated with the Biological Chemistry Graduate Program.